+++ STONG BUY +++
Ausbruch und Rallye noch vor dem Wochenende?!
Anzeige
Talphera - Forum WKN: A3DWPN ISIN: US00444T2096 Kürzel: TLPH Forum: Aktien User: Summer.76
0,864 EUR
+3,78 %+0,032
8. Nov, 20:02:34 Uhr,
Lang & Schwarz
Kommentare 76
Cevo78,
18.09.2023 20:11 Uhr
0
Dem ist glaub langweilig
Kauft halt 10000 stk. 😁
Summer.76,
12.09.2023 20:20 Uhr
0
Insider Buying: CEO Vincent Angotti Acquires 10,000 Shares of AcelRx Pharmaceuticals Inc
https://www.gurufocus.com/news/2083853/insider-buying-ceo-vincent-angotti-acquires-10000-shares-of-acelrx-pharmaceuticals-inc
Summer.76,
18.08.2023 17:13 Uhr
0
HC Wainwright Upgrades AcelRx Pharmaceuticals to Buy From Neutral, Price Target is $8
https://www.marketscreener.com/quote/stock/ACELRX-PHARMACEUTICALS-I-7314079/news/HC-Wainwright-Upgrades-AcelRx-Pharmaceuticals-to-Buy-From-Neutral-Price-Target-is-8-44649944/
Na dann 🙃
Summer.76,
10.08.2023 22:07 Uhr
0
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
https://www.prnewswire.com/news-releases/acelrx-reports-second-quarter-2023-financial-results-and-provides-corporate-update-301897581.html
Capital raise closed in July, led by new healthcare investors; provides access to up to $26.3 million in capital, with $10 million immediately available
AcelRx awaits response to Emergency Use Authorization (EUA) of Niyad™ submitted to the FDA in April; registrational study set to initiate in Q4 2023
Proforma $17.4 million in cash as of June 30, 2023, including gross proceeds from financing closed in July 2023
Senior debt with Oxford fully repaid in Q2 2023
Summer.76,
21.07.2023 16:33 Uhr
0
AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules
https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-closing-of-previously-announced-private-placement-priced-at-the-market-under-nasdaq-rules-301882640.html
Transformative capital raise, led by new investors including Nantahala Capital Management
The private placement provides access to up to $26.3 million of gross proceeds upon the exercise of the milestone-affected warrants
Summer.76,
18.07.2023 15:51 Uhr
0
AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-10-million-private-placement-of-securities-priced-at-the-market-under-nasdaq-rules-301879430.html
Upon the achievement of certain milestones accelerating the warrants' expiration date, AcelRx may receive an additional $16.3 million of gross proceeds if the common warrants are exercised in full
Summer.76,
15.06.2023 22:39 Uhr
0
https://www.acelrx.com/node/14011/html
...On June 15, 2023, the Company received notice from Nasdaq confirming that the Company has cured its bid price deficiency and has regained compliance with the Minimum Bid Price Rule, and that this matter is now closed.
Highländer,
26.05.2023 10:21 Uhr
0
Wie geht es weiter?
https://www.finanznachrichten.de/nachrichten-2023-05/59189716-acelrx-zock-tipp-liefert-107-in-drei-wochen-486.htm
Summer.76,
25.05.2023 18:49 Uhr
0
Die 1 vor dem Komma gab es hier ja länger nicht mehr zu sehen... 🍀
Summer.76,
10.05.2023 22:09 Uhr
0
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-reports-first-quarter-2023-financial
Request for Emergency Use Authorization of Niyad™ submitted to the FDA in April
Divestment of DSUVIA® to Alora Pharmaceuticals closed April 3, 2023
$13.4 million in cash as of March 31, 2023
...
Summer.76,
05.04.2023 17:27 Uhr
0
https://www.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-announces-closing-divestment-dsuviar
Summer.76,
30.03.2023 22:23 Uhr
0
https://seekingalpha.com/news/3952853-acelrx-pharmaceuticals-gaap-eps-of-1_00-beats-1_51-revenue-of-0_25m-misses-4_25m
• AcelRx Pharmaceuticals press release (NASDAQ:ACRX): Q4 GAAP EPS of $1.00 beats by $1.51.
• Revenue of $0.25M (+1150.0% Y/Y) misses by $4.25M.
• Divestment of DSUVIA to Alora Pharmaceuticals expected to close the week of April 3, 2023
Summer.76,
30.03.2023 22:07 Uhr
0
https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-reports-full-year-and-fourth-quarter-2022-financial-results-and-provides-corporate-update-301786311.html
AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
T
TradewindRider,
15.03.2023 19:12 Uhr
0
Schreib ich ab den Laden... Fehlinvest. Klang so gut.
Summer.76,
14.03.2023 15:38 Uhr
1
Der link dazu:
https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-divestment-of-dsuvia-to-alora-pharmaceuticals-301771123.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +10,77 % | |
2 | Vivoryon Therapeutics | -9,21 % | |
3 | MicroStrategy | +1,80 % | |
4 | NVIDIA Hauptdiskussion | +0,01 % | |
5 | MODERNA INC. DL-,0001 Hauptdiskussion | -5,73 % | |
6 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | -3,57 % | |
7 | Lilium Aktie | +17,86 % | |
8 | GAMESTOP Hauptdiskussion | +6,64 % | |
9 | Marathon Digital Holdings | +1,28 % | |
10 | FREYR BATTERY | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +10,77 % | |
2 | Vivoryon Therapeutics | -9,21 % | |
3 | NVIDIA Hauptdiskussion | +0,01 % | |
4 | MicroStrategy | +1,80 % | |
5 | MODERNA INC. DL-,0001 Hauptdiskussion | -5,73 % | |
6 | TILRAY INC. CL.2 DL-,0001 Hauptdiskussion | -3,57 % | |
7 | GAMESTOP Hauptdiskussion | +6,64 % | |
8 | Marathon Digital Holdings | +1,28 % | |
9 | Lilium Aktie | +17,86 % | |
10 | FREYR BATTERY | ±0,00 % | Alle Diskussionen |